Citation Impact
Citing Papers
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
1990 StandoutNature
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Oocytes from Xenopus laevis contain an intrinsic σ2-like binding site
1994
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic
1998
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates
1998
Gi-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies
2009 StandoutNobel
Imidazolones in Diastereoselective Cyclization Reactions and CuII‐Catalysed Cross‐Coupling Reactions
2009 StandoutNobel
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Glutamate uptake
2001 Standout
Control of pain initiation by endogenous cannabinoids
1998 StandoutNature
cDNA cloning and regional distribution of a novel member of the opioid receptor family
1994
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
2010 Standout
OPIOID RECEPTOR SIGNALLING MECHANISMS
1999
Determination of the Amino Acid Residue Involved in [3H]β-Funaltrexamine Covalent Binding in the Cloned Rat µ Opioid Receptor
1996
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
The olfactory bulbectomised rat as a model of depression
2005
The neurobiology of zinc in health and disease
2005 Standout
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
2010 Standout
Selectivity of μ-opioid receptor determined by interfacial residues near third extracellular loop
2000
G protein coupled receptor dimerization: implications in modulating receptor function
2001
σ Receptors: potential medications development target for anti-cocaine agents
2003
Mismatches between neurotransmitter and receptor localizations in brain: observations and implications
1987
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
G Protein-coupled Receptors
1998 StandoutNobel
Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
2004
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region
1991
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
2005
Major Depressive Disorder
2008 Standout
The molecular logic of endocannabinoid signalling
2003 Standout
Pharmacology and mechanisms of opioid analgesic activity
1997
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
1997
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes
2002 StandoutNobel
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys
1999
Dimerization of the δ Opioid Receptor:
1997
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
1995 StandoutNature
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Neurosteroids: Biosynthesis and Function of These Novel Neuromodulators
2000
A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells
2005 StandoutNobel
Withdrawal from Chronic Phencyclidine Treatment Induces Long-Lasting Depression in Brain Reward Function
2002
Sigma1 binding in a human neuroblastoma cell line
1996
Oligomerization of μ- and δ-Opioid Receptors
2000
Dopamine, learning and motivation
2004 Standout
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants
1998
Plasmon-Waveguide Resonance Studies of Ligand Binding to the Human β2-Adrenergic Receptor
2004 StandoutNobel
The Glutamate Hypothesis of Schizophrenia
1997
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
1997 Science
Efficient Synthesis of Diastereomerically Pure Vicinal Diamines: meso-2,3-Bis(methylamino)butane and cis-1,2-Bis(methylamino)cycloalkanes
1997
Mutations in theCaenorhabditis elegansSerotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine
2001 StandoutNobel
Synthesis and structure-activity relationships of novel 2-amino alkyl chromones and related derivatives as a site-selective ligands
1998
Hydrodynamic properties and immunological identification of the sodium- and chloride-coupled glycine transporter.
1993
Myocyte Adrenoceptor Signaling Pathways
2003 StandoutScienceNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Controlling signaling with a specifically designed G i -coupled receptor
1998
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus.
1995
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Agonist-induced conformational changes in the G-protein-coupling domain of the β 2 adrenergic receptor
2001 StandoutNobel
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
1996
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
2000
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice
2002 StandoutNobel
Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors
2006
Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia1Published on the World Wide Web on 12 January 1998.1
1998
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
1995 StandoutScience
Cannabinoid receptor localization in brain.
1990 Standout
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 StandoutScience
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
1999 Standout
Alpha1-adrenergic receptors: new insights and directions.
2001
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
1991 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Works of K.C. Rice being referenced
GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
1994
Chronic administration of morphine and naltrexone up-regulate[3H][d-ala2,d-leu5]enkephalin binding sites by different mechanisms
1988
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.
1996
Dextromethorphan and BD 737, a novel highly selective σ ligand, protect against dynorphin A-induced rat spinal cord injury
1990
Sigma receptors: biology and function.
1990
Effects of phencyclidine on rat prolactin dopamine receptor and locomotor activity
1983
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
1985
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
1991
Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand.
1990
Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
1986
The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
1989
Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
1991
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
1988
Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
1995
Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
1989
Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
1986